Jerry S. Lanchbury - Jul 12, 2021 Form 4 Insider Report for MYRIAD GENETICS INC (MYGN)

Role
Chief Scientific Officer
Signature
By: Nathan A. Smith For: Jerry S. Lanchbury
Stock symbol
MYGN
Transactions as of
Jul 12, 2021
Transactions value $
-$666,889
Form type
4
Date filed
7/14/2021, 05:44 PM
Previous filing
Jul 12, 2021
Next filing
Aug 5, 2021

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction MYGN Common Stock Options Exercise $972K +36.7K +15.78% $26.49 269K Jul 12, 2021 Direct F1
transaction MYGN Common Stock Sale -$1.23M -36.7K -13.63% $33.55 233K Jul 12, 2021 Direct F1, F2
transaction MYGN Common Stock Options Exercise $352K +13.3K +5.72% $26.49 246K Jul 12, 2021 Direct F1
transaction MYGN Common Stock Sale -$446K -13.3K -5.41% $33.55 233K Jul 12, 2021 Direct F1, F2
transaction MYGN Common Stock Options Exercise $87.3K +3.3K +1.42% $26.49 236K Jul 13, 2021 Direct F1
transaction MYGN Common Stock Sale -$111K -3.3K -1.4% $33.69 233K Jul 13, 2021 Direct F1, F3
transaction MYGN Common Stock Options Exercise $1.06M +40K +17.2% $26.49 273K Jul 13, 2021 Direct F1
transaction MYGN Common Stock Sale -$1.35M -40K -14.68% $33.74 233K Jul 13, 2021 Direct F1, F4

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction MYGN Non-Qualified Stock Option (right to buy) Options Exercise $0 -36.7K -33.51% $0.00 72.8K Jul 12, 2021 Common Stock 36.7K $26.49 Direct F1, F5
transaction MYGN Non-Qualified Stock Option (right to buy) Options Exercise $0 -13.3K -18.26% $0.00 59.5K Jul 12, 2021 Common Stock 13.3K $26.49 Direct F1, F5
transaction MYGN Non-Qualified Stock Option (right to buy) Options Exercise $0 -3.3K -5.54% $0.00 56.2K Jul 13, 2021 Common Stock 3.3K $26.49 Direct F1, F5
transaction MYGN Non-Qualified Stock Option (right to buy) Options Exercise $0 -40K -71.14% $0.00 16.2K Jul 13, 2021 Common Stock 40K $26.49 Direct F1, F5
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The transactions reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan.
F2 The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $33.08 to $34.01, inclusive. The Reporting Person undertakes to provide to Myriad Genetics, Inc., any security holder of Myriad Genetics, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
F3 The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $33.205 to $33.95, inclusive. The Reporting Person undertakes to provide to Myriad Genetics, Inc., any security holder of Myriad Genetics, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
F4 The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $33.49 to $33.96, inclusive. The Reporting Person undertakes to provide to Myriad Genetics, Inc., any security holder of Myriad Genetics, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
F5 The shares subject to this option are fully vested and exercisable.